Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
302,717,464
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
117,306,862
-
Shares change
-
+3,256,623
-
Total reported value, excl. options
-
$358,961,836
-
Value change
-
-$19,512,348
-
Put/Call ratio
-
20%
-
Number of buys
-
68
-
Number of sells
-
-67
-
Price
-
$3.06
Significant Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q1 2020
160 filings reported holding PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 as of Q1 2020.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117,306,862 shares
of 302,717,464 outstanding shares and own 39% of the company stock.
Largest 10 shareholders include BlackRock Inc. (12,834,826 shares), VANGUARD GROUP INC (7,467,151 shares), Bellevue Group AG (7,378,791 shares), Capital International Investors (6,796,300 shares), Kite Lake Capital Management (UK) LLP (5,490,994 shares), Capital World Investors (5,446,000 shares), WATER ISLAND CAPITAL LLC (5,443,564 shares), Weiss Multi-Strategy Advisers LLC (4,258,534 shares), ARK Investment Management LLC (4,193,059 shares), and STATE STREET CORP (3,582,219 shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.